-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 11487 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET-32a
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 5900
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namehuntingtin, exon 1, 16 glutamines
-
Alt namehuntingtin (Huntington disease)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)279
-
Mutationhuntingtin exon 1 with 16 glutamines, vector modified-removed N-terminal His tag by digesting vector with MscI and NspV, filling in and blunt-end-ligating back together.
-
GenBank IDNM_002111
-
Entrez GeneHTT (a.k.a. HD, IT15, LOMARS)
-
Tags
/ Fusion Proteins
- Trx (N terminal on backbone)
- His (C terminal on insert)
- His (out of frame) (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NcoI (not destroyed)
- 3′ cloning site BamHI (not destroyed)
- 5′ sequencing primer T7 promoter
- 3′ sequencing primer T7 terminator (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byR. Myers
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pET32a-HD16Q was a gift from Pamela Bjorkman (Addgene plasmid # 11487 ; http://n2t.net/addgene:11487 ; RRID:Addgene_11487) -
For your References section:
Inaugural Article: A linear lattice model for polyglutamine in CAG-expansion diseases. Bennett MJ, Huey-Tubman KE, Herr AB, West AP, Ross SA, Bjorkman PJ. Proc Natl Acad Sci U S A. 2002 Sep 3. 99(18):11634-9. 10.1073/pnas.182393899 PubMed 12193654